Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report

American Journal of Hematology
Alex Costea, Geetha Bhat

Abstract

Homocysteine has been recognized as a risk factor for atherosclerosis and arterial and venous thrombosis. Heart transplant patients have an increased prevalence of hyperhomocysteinemia. High homocysteine levels in transplant patients may promote development of cardiac allograft vasculopathy, but there is minimal information regarding the risk of venous thrombosis. The current case report illustrates the association of increased levels of homocysteine and hypercoagulable syndrome in a 36-year-old heart transplant patient with no previous history of clotting disorder. Both elevated homocysteine levels and extensive venous thrombosis responded promptly to treatment with a folate/B12/B6 vitamin combination and enoxaparin.

References

Feb 1, 1995·Mayo Clinic Proceedings·P B BergerC G McGregor
Mar 21, 1996·The New England Journal of Medicine·M den HeijerF R Rosendaal
Mar 1, 1996·Journal of the American College of Cardiology·E L MayerK Robinson
Dec 18, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·L PotenaA Branzi
Nov 27, 2002·Transplantation·Angel Caldera, G William Dec

❮ Previous
Next ❯

Citations

Feb 22, 2007·Plastic and Reconstructive Surgery·George BroughtonRod J Rohrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Carlos A LabarrereHector L DiCarlo
Journal of Cardiovascular Electrophysiology
Andrea SarkozyPedro Brugada
© 2021 Meta ULC. All rights reserved